Emicizumab state-of-the-art update.

Johnny N Mahlangu Alfonso Iorio Tami Livnat

Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2022)

The current global rollout of emicizumab is remarkable, and versatile dosing regimens and evolving pharmacokinetic tools such as the Calibra® and WAPPS-Hemo platforms make it a treatment choice available also for pharmacokinetic guided personalised treatment. Data from paediatric studies are consistent with those seen in adolescent and adult Haemophilia A.

Keyphrases

young adults
emergency department
mental health
intensive care unit
electronic health record
combination therapy
big data
childhood cancer
smoking cessation